National Healthcare Properties Inc

Aktienanalyse zu National Healthcare Properties Inc (NHP)

$15.800

+1.125 (+7.12%)Zum Schluss

Loading chart…
Hoch
15.830
Eröffnung
14.550
Volumengewichteter Durchschnittskurs
15.31
Volumen
2.35M
Marktkap.
—
Tief
14.310
Umsatz
35.97M
EV/EBITDA, TTM
13.61

National Healthcare Properties, Inc. is a real estate investment trust, which is focused on acquiring, owning and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. It has two operating and reportable segments: SHOP and OMF. In the SHOP segment, the Company invests in senior housing properties. In the OMF segment, it owns, manages and leases single and multi-tenant OMFs. It owns over 167 properties and a land parcel located in 29 states, consisting of 37 senior housing communities, with 3,615 units, in its SHOP segment and 130 outpatient medical facilities, with approximately 3.7 million square feet in OMF segment. Its properties include Surgery Center of Temple - Temple, TX, Greenville Health System - Greenville, SC; Stockbridge Family Medical - Stockbridge, GA; Berwyn Medical Center - Berwyn, IL; Countryside Medical Arts - Safety Harbor, FL, and others.

nhpreit.com

KI-Analyse of National Healthcare Properties Inc (NHP)

Halten

Currently, National Healthcare Properties, Inc. (NHP) is not a strong buy. The stock is trading at $15.11, with a recent RSI of 38.944, indicating it is nearing oversold territory. However, the company has reported a significant net loss of $8.14 million in Q2 2026, which raises concerns about its profitability. Despite a positive year-to-date change of +25.92%, the recent 5-day change of -2.80% suggests short-term weakness. The analyst price targets suggest an upside potential of approximately 12% to 39% from the current price, but the ongoing net losses and a high debt-to-equity ratio of 80.23% present risks that investors should consider before making a purchase.

Bewertungskennzahlen

Das aktuelle erwartete KGV von National Healthcare Properties Inc (NHP) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
15.42
Aktuelles EV/EBITDA
13.61
Überbewertet
17.42
Unterbewertet
13.41

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
2.63
Aktuelles P/S
2.28
Überbewertet
2.98
Unterbewertet
2.28

Whales, die NHP halten

L

LaSalle Investment Management Securities, LLC

+ HältNHP

-7.16%

3-Monats-Rendite

NHP FAQ – beantwortet von Alphio AI

National Healthcare Properties, Inc. is a real estate investment trust, which is focused on acquiring, owning and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. It has two operating and reportable segments: SHOP and OMF. In the SHOP segment, the Company invests in senior housing properties. In the OMF segment, it owns, manages and leases single and multi-tenant OMFs. It owns over 167 properties and a land parcel located in 29 states, consisting of 37 senior housing communities, with 3,615 units, in its SHOP segment and 130 outpatient medical facilities, with approximately 3.7 million square feet in OMF segment. Its properties include Surgery Center of Temple - Temple, TX, Greenville Health System - Greenville, SC; Stockbridge Family Medical - Stockbridge, GA; Berwyn Medical Center - Berwyn, IL; Countryside Medical Arts - Safety Harbor, FL, and others. It operates in the Real Estate sector.

Currently, National Healthcare Properties, Inc. (NHP) is not a strong buy. The stock is trading at $15.11, with a recent RSI of 38.944, indicating it is nearing oversold territory. However, the company has reported a significant net loss of $8.14 million in Q2 2026, which raises concerns about its profitability. Despite a positive year-to-date change of +25.92%, the recent 5-day change of -2.80% suggests short-term weakness. The analyst price targets suggest an upside potential of approximately 12% to 39% from the current price, but the ongoing net losses and a high debt-to-equity ratio of 80.23% present risks that investors should consider before making a purchase.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln